| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |